Cvs Health Corporation (CVS) |
|
Price: $77.5700
$0.17
0.220%
|
Day's High:
| $77.64
| Week Perf:
| 3.14 %
|
Day's Low: |
$ 76.39 |
30 Day Perf: |
1.27 % |
Volume (M): |
7,117 |
52 Wk High: |
$ 83.25 |
Volume (M$): |
$ 552,097 |
52 Wk Avg: |
$72.22 |
Open: |
$77.26 |
52 Wk Low: |
$64.41 |
|
|
Market Capitalization (Millions $) |
100,038 |
Shares
Outstanding (Millions) |
1,290 |
Employees |
300,000 |
Revenues (TTM) (Millions $) |
357,776 |
Net Income (TTM) (Millions $) |
8,368 |
Cash Flow (TTM) (Millions $) |
-4,780 |
Capital Exp. (TTM) (Millions $) |
3,031 |
Cvs Health Corporation
CVS Corporation is a leader in the retail drugstore industry in the United States
with net sales of $26.6 billion in 2003, making us the second largest retail drugstore
chain based on sales. We operate 4,179 retail and specialty pharmacy stores in
32 states and the District of Columbia. We currently operate in 68 of the top
100 U.S. drugstore markets and hold the number one market share in 32 of these
markets. Overall, we hold the number one or number two market share in 62% of
the markets in which we operate.
Company Address: One CVS Drive, Woonsocket, 2895 RI
Company Phone Number: 765-1500 Stock Exchange / Ticker: NYSE CVS
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Cvs Health Corporation
CVS Health Corporation, a leading Pharmacy Services & Retail Drugstore company, experienced a slight decline in its shares during the month of February 2024. The shares dropped by -0.22%, bringing the year-to-date performance to -8.77%. Currently trading on the NYSE, CVS Health Corporation's shares are valued at 1% above its 52-week average. During the period from October to December 2023, CVS Health Corporation witnessed a reduction in its earnings per share (EPS) despite a significant increase in revenue. The profitability decreased by -9.26% to $1.59 per share, while the revenue grew extensively by 11.887% to $93.81 billion compared to the same period the previous year. This growth in revenue outpaced the top-line performance of most other companies in the Pharmacy Services & Retail Drugstore sector, as they reported an average revenue advance of 11.61% in the fourth quarter of 2023 compared to the previous year.
|
Cvs Health Corporation
CVS Health Corporation, a leading player in the Pharmacy Services & Retail Drugstore sector, has bucked the trend of declining orders and fading revenue that has plagued many companies in the industry. In its fiscal third quarter of 2023, the company reported positive profits of $1.75 per share, a significant improvement from the loss of $2.60 per share in the same period last year. This represents a commendable turnaround for CVS Health Corporation. Net profit per share also saw a healthy increase of 18.24% from the prior financial reporting period, reaching $1.48 per share. Additionally, the company witnessed a notable growth of 10.603% in revenue, which amounted to $89.76 billion compared to $81.16 billion in the corresponding period a year ago. Sequentially, revenue advanced slightly by 0.948% from $88.92 billion.
|
Cvs Health Corporation
As a stock market journalist, I have been closely following the financial results of CVS Health Corporation. In the second quarter of 2023, CVS experienced a reduction in earnings per share (EPS) despite a respectable growth in revenue. The net profit per share dropped by -33.63% to $1.48 per share, while revenue increased by 10.275% to $88.92 billion compared to the same quarter last year. However, it is important to note that CVS Health Corporation has managed to outperform its industry contemporaries in terms of revenue growth. While the Pharmacy Services & Retail Drugstore industry showed a 9.87% revenue growth during the same period, CVS saw a higher growth rate of 10.275%. This signifies the company's success in generating robust top-line figures.
|
Cvs Health Corporation
CVS Health Corporation is a well-known name in the healthcare industry. With a focus on providing healthcare services and products to millions of people across the United States, CVS Health Corporation has become one of the largest integrated pharmacy chains in the world. However, the most recent financial analysis reveals that CVS Health Corporation has confronted a reduction in EPS, despite revenue elevation in the most recent fiscal period. In the most recent fiscal period, CVS Health Corporation reported that profits decreased by -5.17% to $1.65 per share, despite an impressive increase in revenue by 11.001% to $85.28 billion, from the comparable financial reporting period a year ago. Compared to the preceding financial reporting period, EPS decreased by -5.82% from $1.75 per share while revenue increased by 1.708% from $83.85 billion.
|
Per Share |
Current |
Earnings (TTM) |
6.47 $ |
Revenues (TTM) |
277.42 $
|
Cash Flow (TTM) |
- |
Cash |
8.88 $
|
Book Value |
59.42 $
|
Dividend (TTM) |
2.42 $ |
|
Per Share |
|
Earnings (TTM) |
6.47 $
|
Revenues (TTM) |
277.42 $ |
Cash Flow (TTM) |
- |
Cash |
8.88 $
|
Book Value |
59.42 $ |
Dividend (TTM) |
2.42 $ |
|
|
|
Retail Pharmacy |
|
Segment |
|
|
of total Revenue |
PBM |
|
Segment |
|
|
of total Revenue |
PBM Mail choice |
|
Segment |
|
|
of total Revenue |
PBM Pharmacy network |
|
Segment |
|
|
of total Revenue |
PBM Other |
|
Segment |
|
|
of total Revenue |
|
Cvs Health's Operating Statistics
|
Decrease / Increase
|
|
|
|
|
Mail choice claims processed (millions) |
|
|
|
Pharmacy network claims processed (millions) |
|
|
|
Pharmacy claims processed (millions) |
|
|
|
Avg. Rev. Per Mail choice claim ($) |
|
|
|
Avg. Rev. Per Network claim ($) |
|
|
|
Retail prescriptions filled (millions) |
|
|
|
Retail drugstores operated |
|
|
|
Avg. Rev. Per Retail drugstore (thousands $) |
|
|
|
|
|